-
detectors. There is an optional opportunity to contribute a limited fraction of effort to research within the CMS experiment at CERN, particularly were expertise in ML/AI, data analysis, or detector-related
-
. This work has the potential to transform how both the targets and therapies for disease are identified. We aim to revolutionize the process of drug discovery in several projects, including: Identify
-
research • Deep learning and predictive modeling • Natural language processing and large language models for biomedical data • Drug response prediction and treatment optimization • Biomedical knowledge
-
innovation behaviors and processes and cultivate innovation ecosystems in complex organizations tackling multi-stakeholder, multi-attribute challenges. -Contribute to the Institute for Innovation Science's
-
microenvironment, and other biological processes. Conduct preclinical studies using in vivo disease models (cancer, inflammation, organ injury, etc.) and new alternative methodologies (advanced biological models